Comparison of outcomes of hysteroscopic myomectomy of type 2 submucous fibroids greater than 4 cm in diameter via pretreatment with HIFU or GnRH-a

References

• Day Baird D, Dunson DB, Hill MC, et al. High cumulative incidence of uterine leiomyoma in black and white women: ultrasound evidence. Am J Obstet Gynecol. 2003;188(1):100–107.
   PubMed Web of Science ®Google Scholar
• Chabbert-Buffet N, Esber N, Bouchard P. Fibroid growth and medical options for treatment. Fertil Steril. 2014;102(3):630–639.
   PubMed Web of Science ®Google Scholar
• Munro MG, Critchley HO, Broder MS, FIGO Working Group on Menstrual Disorders, et al. FIGO classification system (PALM-COEIN) for causes of abnormal uterine bleeding in nongravid women of reproductive age. Int J Gynaecol Obstet. 2011;113(1):3–13.
   PubMed Web of Science ®Google Scholar
• Laganà AS, Alonso Pacheco L, Tinelli A, et al. Management of asymptomatic submucous myomas in women of reproductive age: a consensus statement from the Global Congress on Hysteroscopy Scientific Committee. J Minim Invasive Gynecol. 2019;26(3):381–383.
   PubMed Web of Science ®Google Scholar
• Lasmar RB, Barrozo PRM, Dias R, et al. Submucous myomas: a new presurgical classification to evaluate the viability of hysteroscopic surgical treatment – preliminary report. J Minim Invasive Gynecol. 2005;12(4):308–311.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Sun L, Guo Y, et al. The impact of preoperative gonadotropin-releasing hormone agonist treatment on women with uterine fibroids: a meta-analysis. Obstet Gynecol Surv. 2014;69(2):100–108.
   PubMed Web of Science ®Google Scholar
• Lee GY, Han JI, Heo HJ. Severe hypocalcemia caused by absorption of sorbitol-mannitol solution during hysteroscopy. J Korean Med Sci. 2009;24(3):532–534.
   PubMed Web of Science ®Google Scholar
• Lethaby A, Puscasiu L, Vollenhoven B. Preoperative medical therapy before surgery for uterine fibroids. Cochrane Database Syst Rev. 2017;11:D547.
   Google Scholar
• Ukybassova T, Terzic M, Dotlic J, et al. Evaluation of uterine artery embolization on myoma shrinkage: results from a large cohort analysis. Gynecol Minim Invasive Ther. 2019;8(4):165–171.
   PubMed Web of Science ®Google Scholar
• Vercellini P, Carmignani L, Rubino T, et al. Surgery for deep endometriosis: a pathogenesis-oriented approach. Gynecol Obstet Invest. 2009;68(2):88–103.
   PubMed Web of Science ®Google Scholar
• Lee J, Hong G, Lee K, et al. Safety and efficacy of ultrasound-guided high-intensity focused ultrasound treatment for uterine fibroids and adenomyosis. Ultrasound Med Biol. 2019;45(12):3214–3221.
   PubMed Web of Science ®Google Scholar
• Wang Y, Liu X, Wang W, et al. Long-term clinical outcomes of US-guided high-intensity focused ultrasound ablation for symptomatic submucosal fibroids: a retrospective comparison with uterus–sparing surgery. Acad Radiol. 2020;S1076-6332(20)30286–5.
   Web of Science ®Google Scholar
• Wu G, Li R, He M, et al. A comparison of the pregnancy outcomes between ultrasound-guided high-intensity focused ultrasound ablation and laparoscopic myomectomy for uterine fibroids: a comparative study. Int J Hyperthermia. 2020;37(1):617–623.
   PubMed Web of Science ®Google Scholar
• Qu D, Chen Y, Yang M, et al. High-intensity focused ultrasound for treatment of Type 2 submucous myomas more than 4 centimeters in diameter prior to hysteroscopic myomectomy. J Minim Invasive Gynecol. 2020;27(5):1076–1080.
   PubMed Web of Science ®Google Scholar
• Chen J, Chen W, Zhang L, et al. Safety of ultrasound-guided ultrasound ablation for uterine fibroids and adenomyosis: a review of 9988 cases. Ultrason Sonochem. 2015;27:671–676.
   PubMed Web of Science ®Google Scholar
• Chen Y, Jiang J, Zeng Y, et al. Effects of a microbubble ultrasound contrast agent on high-intensity focused ultrasound for uterine fibroids: a randomised controlled trial. Int J Hyperthermia. 2018;34(8):1311–1315.
   PubMed Web of Science ®Google Scholar
• Liao W, Ying T, Shen H, et al. Combined treatment for big submucosal myoma with High Intensity Focused Ultrasound and hysteroscopic resection. Taiwan J Obstet Gynecol. 2019;58(6):888–890.
   PubMed Web of Science ®Google Scholar
• Grigoriadis C, Papconstantinou E, Mellou A, et al. Clinicopathological changes of uterine leiomyomas after GnRH agonist therapy. Clin Exp Obstet Gynecol. 2012;39(2):191–194.
   PubMed Web of Science ®Google Scholar
• Wang W, Wang Y, Wang T, et al. Safety and efficacy of US-guided high-intensity focused ultrasound for treatment of submucosal fibroids. Eur Radiol. 2012;22(11):2553–2558.
   PubMed Web of Science ®Google Scholar
• Corrêa TD, Caetano IM, Saraiva PHT, et al. Use of GnRH analogues in the reduction of submucous fibroid for surgical hysteroscopy: a systematic review and meta-analysis. Revista Brasileira de Ginecologia e Obstetrícia/RBGO Gynecol Obstet. 2020,42(10):649–658.
   PubMedGoogle Scholar
• Wang PH, Lee WL, Chao HT, et al. Relationship between hormone receptor concentration and tumor shrinkage in uterine myoma after treatment with a GnRHa. Zhonghua Yi Xue Za Zhi (Taipei). 1999;62(5):294–299.
   PubMedGoogle Scholar
• Chia CC, Huang SC, Chen SS, et al. Ultrasonographic evaluation of the change in uterine fibroids induced by treatment with a GnRH analog. Taiwan J Obstet Gynecol. 2006;45(2):124–128.
   PubMedGoogle Scholar
• Di Lieto A, De Falco M, Pollio F, et al. Clinical response, vascular change, and angiogenesis in gonadotropin-releasing hormone analogue-treated women with uterine myomas. J Soc Gynecol Investig. 2005; 12(2):123–128.
   PubMedGoogle Scholar
• Di Lieto A, De Falco M, Mansueto G, et al. Preoperative administration of GnRH -a plus tibolone to premenopausal women with uterine fibroids:evaluation of the clinical response, the immunohistochemical expression of PDGF.bFGF and VEGF and the vascular pattern. Steroids. 2005;70(2):95–102.
   PubMed Web of Science ®Google Scholar
• Palomba S, Orio F, Jr, Russo T, et al. Long-term effectiveness and safety of GnRH agonist plus raloxifene administration in women with uterine leiomyomas. Hum Reprod. 2004;19(6):1308–1314.
   PubMed Web of Science ®Google Scholar
• Fitzgerald JJ, Davitt JM, Frank SR, et al. Critically high carboxyhemoglobin level following extensive hysteroscopic myomectomy. J Minim Invasive Gynecol. 2020;27(2):548–550.
   PubMed Web of Science ®Google Scholar